Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo

Class:IdLiteratureReference:9014938
_displayNameCombined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo
_timestamp2017-08-07 10:58:51
author[Person:9014933] Stoklasek, Thomas A
[Person:9014939] Schluns, Kimberly S
[Person:1678942] Lefrançois, L
created[InstanceEdit:9014925] Duenas, Corina, 2017-08-07
journalJ. Immunol.
pages6072-80
pubMedIdentifier17056533
titleCombined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo
volume177
year2006
(literatureReference)[Summation:8983289] Inferred from mouse: Interleukin-15 (IL15) stimulates the ph...
[Summation:8983290] Inferred from mouse:GRB2 is recruited by phosphorylated SHC1...
[Summation:8983296] Coimmunoprecipitation studies show that SHC transforming pro...
[Summation:9009699] Inferred from mouse: Interleukin-2 receptor subunit beta (IL...
[Summation:9009850] Interleukin-2 receptor subunit beta (IL2RB, IL2Rβ) and Cytok...
[Change default viewing format]
No pathways have been reviewed or authored by Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo (9014938)